OSSIO Raises $27.6 Million to Accelerate Its Commercial Engine as High Demand for Bio-Integrative Fixation Technology Continues
Ossio Closes $38.5M Series C Financing
Investment
OSSIO Announces U.S. Launch and First Commercial Use of OSSIOfiber® Suture Anchors, Expanding Patient Access to Growing Portfolio of Bio-Integrative Orthopedic Fixation Technology
OSSIO Achieves Third FDA Clearance in 4 Months for OSSIOfiber® Implants; Prepares to Expand Patient Access to Bio-Integrative Orthopedic Fixation Technology Portfolio in Q2/Q3
CustomersExpand
OSSIO Wins GPO Contract for Bio-Integrative Fixation Tech
Customers
Ossio gets FDA clearance for OSSIOfiber Hammertoe Fixation System
CustomersInvestment
OSSIO Receives Prestigious Frost & Sullivan New Product Innovation Award for its Breakthrough OSSIOfiberTM Intelligent Bone Regeneration Technology
OSSIO Announces U.S. Launch and First Commercial Use of the New OSSIOfiberTM Bone Pin for Hammertoe Correction
OSSIO Secures $22 Million in Financing
Ossio prepares for US market entrance with new headquarters - 4 details
Expand